Australia's Genesis makes biolabs investment
Genesis Capital, a mid-market Australian private equity firm specialising in healthcare, has acquired a majority stake in Crux Biolabs, a contract research organisation (CRO) based in the Melbourne suburbs.
The size of the deal was not disclosed. It comes from Genesis’ debut fund – one of few dedicated healthcare private equity vehicles operating in the local market – which closed on AUD 190m (USD 142m)...
More on Australasia
Latest News
Japan healthcare start-up Ubie closes $43m Series C
Japanese healthcare technology start-up Ubie has closed its Series C round on JPY6.3bn (USD 43.2m) with the latest tranche featuring PE-owned pharmacy chain operator Sogo Medical.
Proterra backs Singapore biodiesel player
Specialist food and agriculture investor Proterra Investment Partners has agreed to invest in Aperion Bioenergy, a Singapore-based bioenergy producer that sources used cooking oil for feedstocks.
Dymon Asia closes Fund III at $650m hard cap
Dymon Asia Private Equity (DAPE) has closed its third Southeast Asia middle market private equity fund at a hard cap of USD 650m, beating a target of USD 550m.
Australia gaming, e-sports start-up gets $12m
Gamurs, a Sydney-headquartered media company specialising in gaming, e-sports, and entertainment, has secured USD 12m in Series A funding.